Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond Gujarat and Tamil Nadu to Establish Shared Technical Facilities for Space Manufacturing Samsung Electronics Shares Surge 6 as Union Suspends Strike Following Tentative Wage Agreement Surge in Treasury Yields Prompts Bond Investors to Seek Higher Returns Beyond RiskFree Assets Microsofts AI Cost Dilemma When Automation Bills Exceed Human Payroll AMD Expands Taiwan Production Capacity as Global CPU Supply Constraints Intensify PASG Q1 2026 Earnings Narrowerthanexpected loss lifts shares Uber Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Declines DLPN Q1 2026 Earnings WiderthanExpected Loss Pressures Sentiment as Revenue Remains Undisclosed PROV Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally CCAP Q1 2026 Earnings Narrow EPS Miss Amid Steady Portfolio Performance Airgain AIRG Edges Lower as Stock Tests Key Support Near 661 Turning Point Brands TPB Faces Headwinds Hovers Near Key Support Eaton Vance Senior FloatingRate Fund EFR Holds Steady at 105 Amid Narrow Trading Range Volaris VLRS Surges on Strong Volume Key Levels to Watch After 627 Gain Kura Oncology KURA Stages a Rally Testing Key Resistance at 12 Germany Resists EU Pressure for Harder Line on China Pursues Closer Industrial Ties DG Q1 2026 Earnings EPS Beats Estimates as Dollar General Surpasses Expectations C3ai AI Nears Support After Slight Decline Holding Key Technical Levels FRO Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower Akamais 26 Billion Debt Strategy Aiming to Build an AI Edge Infrastructure PFLT Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Challenging Rate Environment My Size Inc MYSZ Q4 2025 Earnings EPS Misses Estimates as Shares Decline NCMI Q1 2026 Earnings EPS Misses Estimates Amid Cinema Advertising Headwinds Stock Edges Higher CVKD Q1 2026 Earnings Narrowing Losses and Steady Progress in Clinical Pipeline Aaron Carter Wrongful Death Case Highlights Liability Risks for Physicians and Pharmacies in Opioid Crisis